Michael S. Anderson, Chief Executive Officer at AVADEL PHARMACEUTICALS PLC (AVDL), bought 4,000 shares at $9.80 ($39K) on 2017-09-12, disclosed to the SEC on 2017-09-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| AVDL | BUY | 2018-05-29 | $19K | — | Filing → |
| AVDL | BUY | 2017-12-11 | $44K | — | Filing → |
| AVDL | BUY | 2017-05-22 | $25K | — | Filing → |